Latest News and Press Releases

Company is evaluating IMSB301 in a Phase 1 clinical trial in healthy volunteers and plans to move rapidly into Phase 1b/2 clinical studies in patients with AGS, lupus and other cGAS-driven diseases ...

NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022...

NEW YORK, June 11, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the...

NEW YORK, May 29, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in...

Kuehn Law Encourages AGS, FUSN, CVLY, and DRQ Investors to Contact Law Firm

ROME, March 15, 2024 (GLOBE NEWSWIRE) -- NetBet Italia è felice di annunciare una nuova collaborazione con AGS. Questa nuova unione metterà tutti i migliori giochi AGS a disposizione degli utenti...

ROME, March 15, 2024 (GLOBE NEWSWIRE) -- NetBet Italy is happy to announce a brand new partnership with provider AGS. This exciting news means that all the top games from AGS will be available to...

LOS ANGELES, Aug. 24, 2020 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...

LOS ANGELES, Aug. 19, 2020 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming August 24, 2020 deadline to file a lead plaintiff motion in the class action...

WILMINGTON, Del., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. reminds investors of upcoming deadlines involving securities fraud class action lawsuits commenced against the...